Social conflict is a powerful experience that contributes to the establishment of dominant-subordinate hierarchies in many species and produces a host of physiological and behavioral changes, particularly in the defeated animal. For example, social defeat and subordination stress result in increased levels of plasma adrenocorticotrophin (ACTH) and glucocorticoids (Huhman et al. 1991; Blanchard et al. 1993 Blanchard et al. , 1995 , reduced levels of testosterone (Huhman et al. 1991; Blanchard et al. 1995) and immune functioning (Jasnow and Huhman 2001) , and changes in body weight (Blanchard et al. 1995; Foster et al. 2006; Solomon et al. 2007) . Behaviorally, social defeat has been shown to heighten levels of fear and anxiety-related behaviors such as freezing and risk assessment (Blanchard and Blanchard 1990) while reducing aggression and reproductive behavior (Blanchard and Blanchard 1990; Blanchard, et al. 1993 Blanchard, et al. , 1995 .
For the past several years, our laboratory has used an ethologically relevant model of social stress called conditioned defeat (Potegal et al. 1993) in Syrian hamsters (Mesocricetus auratus). Hamsters are an ideal species with which to study social defeat because they are solitary animals and are highly territorial. In a laboratory environment, a resident hamster will reliably attack and defeat an intruder placed into its home cage. Subsequently, however, the defeated animal instead produces only high levels of submissive and defensive behaviors (flight, upright defense, tail lift) and no aggressive behavior even when a smaller, nonaggressive intruder is placed into its own home cage. This behavioral response to social defeat is prolonged, lasting at least 1 mo in the majority of animals (Huhman et al. 2003) .
Although the neurobiological mechanisms underlying conditioned defeat are just beginning to be elucidated, the neural systems underlying conditioned fear in more controlled, but perhaps less biologically relevant, models have been well characterized. A large number of studies have implicated the amygdala as a key structure mediating the acquisition and expression of conditioned fear. For example, both pre-and post-training lesions of the central and basolateral complex of the amygdala decrease conditioned freezing to shock or to contextual cues paired with shock (Blanchard and Blanchard 1972; LeDoux et al. 1990; Roozendaal et al. 1991; Helmstetter 1992; Phillips and LeDoux 1992; Sananes and Davis 1992) . Together, these studies indicate that the amygdala plays an essential role in fear learning. Indeed, the basolateral complex (BLA) is believed to function as the convergence point for sensory input related to conditioned fear as well as serving as an important site for synaptic plasticity (Fanselow and LeDoux 1999) . Several studies have shown that infusion of the NMDA receptor antagonist DL-2-amino-5phosphonopentanoic acid (AP5) into the BLA blocks the acquisition of conditioned freezing and fear-potentiated startle (Campeau et al. 1992; Gewirtz and Davis 1997; Lee and Kim 1998) , and subsequent studies have implicated the NR2B subunit of the NMDA receptor complex in the BLA as playing an especially important role in the plasticity underlying conditioned fear (Tang et al. 1999; Rodrigues et al. 2001; Rattiner et al. 2004 ). Additionally, more recent studies are beginning to implicate the BLA as the site of LTP-like mechanisms that may underlie the cellular basis of conditioned fear (LeDoux 2000; Maren 2001 ). Finally, site-specific injections of anisomycin, a protein synthesis inhibitor, into the BLA impair the acquisition of auditory fear conditioning in a dose-dependent manner (Schafe and LeDoux 2000) , presumably via its blockade of cellular processes necessary for the formation of long-term memory (Bourtchouladze et al. 1998; Schafe and LeDoux 2000; Parsons et al. 2006) .
Although conditioned fear has proven to be invaluable in elucidating the neurobiological mechanisms underlying emotional learning and plasticity, one drawback of the traditional models is the use of an artificial, unimodal stimulus (such as electric shock or a loud sound) to elicit fear responses. On the other hand, conditioned defeat is an ethologically relevant model of fear, wherein animals are allowed to freely interact in a seminatural environment. Conditioned defeat therefore provides an opportunity to study conditioned fear in response to more natural, multimodal cues, allowing us to potentially study a broader neural circuit than is possible with many other models of conditioned fear.
Using our social defeat model, we have demonstrated that the amygdala is critically involved in the acquisition and expression of conditioned defeat. Temporary inactivation of the central (CeA) and basolateral complex of the amygdala via muscimol injections causes a reduction in submissive behavior in animals that have been previously defeated (Jasnow and Huhman 2001) . Additionally, blockade of the NR2B receptor subunit in the BLA specifically disrupts the acquisition, but not expression, of conditioned defeat (Day et al. 2004 ). These results are consistent with studies using traditional models of conditioned fear such as classical Pavlovian fear conditioning and fear-potentiated startle and support the hypothesis that conditioned defeat is an ethologically relevant form of fear conditioning. While there is substantial evidence implicating the CeA and BLA in the acquisition and expression of conditioned fear and conditioned defeat, there is relatively little research focusing on the other subnuclei of the amygdala, most notably the medial nucleus (MeA). Indeed, the vast majority of studies examining the MeA have focused on its role in the detection and modulation of biologically relevant odors, including those related to reproductive (Lehman and Winans 1982; Newman 1999; Meredith and Westberry 2004) and defensive behaviors Canteras 2002; Li et al. 2004; Markham et al. 2004; Blanchard et al. 2005; Muller and Fendt 2006) .
In addition to its role in the detection of biologically relevant odor stimuli, evidence is beginning to indicate that the MeA may also serve a modulatory role in certain types of fear conditioning. For example, Luiten et al. (1985) were among the first to demonstrate a role of the MeA in conditioned fear. Although this study did not specifically examine the role of biological odorants in conditioned fear, it nevertheless showed that lesions of the MeA blocked conditioned avoidance of a dominant opponent in defeated rats. These, and other (Li et al. 2004; Markham et al. 2004) , studies suggest that the MeA may function specifically as a modulator of conditioned fear related to odor cues. Another study by Walker et al. (2005) found that infusion of both the AMPA/kainate receptor antagonist NBQX and the NMDA receptor antagonist AP5 into the MeA failed to disrupt fear conditioning to an olfactory conditioned stimulus (CS). In contrast, pretest infusion of NBQX into the MeA blocked the expression of fear-potentiated startle. These results suggest that the MeA is only involved in the expression, but not acquisition, of conditioned fear. However, it is also possible that the lack of effect seen on conditioning in the Walker study can be attributed to the use of amyl acetate, a non-biological odor stimulus. Considering the high degree of connectivity between the accessory olfactory bulb and the MeA (the vomeronasal pathway), the use of a more biologically relevant odor stimulus, such as that associated with a conspecific, may be more appropriate.
Experimental evidence has therefore clearly indicated the importance of the BLA in the acquisition and/or expression of conditioned fear using a variety of models including conditioned defeat, fear-potentiated startle, and conditioned freezing. However, as stated above, very few studies have examined how other subnuclei of the amygdala may also be involved in these processes. Thus, in the present study, we first tested whether the MeA is a component of the neural circuitry for conditioned defeat. In Experiments 1 and 2, we tested this hypothesis by microinfusing the GABA A agonist muscimol into the MeA either prior to initial defeat (acquisition phase) or prior to testing with a non-aggressive intruder (expression phase). Next, we asked whether memory consolidation for social defeat occurs in the MeA or the BLA. This was tested in Experiment 3 by microinfusing the protein synthesis inhibitor anisomycin into either the MeA or BLA prior to the acquisition phase (initial defeat training).
Results
Experiment 1: Effect of muscimol in the MeA on acquisition of conditioned defeat Figure 1 shows the injection sites for animals in Experiment 1. The injection needles were localized within 0.3 mm of the medial amygdala in 23 of the 42 cannulated animals. Other subjects had cannula placements that missed the MeA bilaterally (n = 7) but were located between 0.30 mm and 0.50 mm from the MeA. These animals were included in an anatomical control group. The remaining animals had unilateral placements (n = 6), or the infusion sites could not be verified because of occluded cannula at the time of the dye injection (n = 6), and these animals were removed from the study.
Animals receiving 1.1 nmol (low dose) and 2.2 nmol (high dose) of muscimol displayed a significant reduction of conditioned defeat-related behaviors, including less submissive/ defensiveness and higher levels of social investigation compared to the vehicle group (P < 0.01 and P < 0.05, respectively) ( Fig. 2 ). No significant differences were observed between the two muscimol groups. Non-social behaviors showed no significant differences for all groups, regardless of dose, and no instances of aggression were found. Additionally, behavioral analysis of the ana- Cold Spring Harbor Laboratory Press on November 7, 2016 -Published by learnmem.cshlp.org Downloaded from tomical controls (injection sites localized 0.3-0.5 mm from the MeA) showed no statistical difference from the vehicle control group, indicating that the effects of muscimol in the MeA on conditioned defeat were highly site-specific.
As indicated in Table 1 , the resident aggressor (RA) was equally likely to attack the muscimol and vehicle control groups, as shown by the latency to first attack and total attack duration times, indicating that muscimol infusions did not alter the normal behavioral profile of the resident aggressors toward the experimental animals.
Experiment 2: Effect of muscimol in the MeA on expression of conditioned defeat Figure 3 shows the injection sites for animals in Experiment 2. The injection needles were localized within 0.3 mm of the MeA in 24 of the 40 cannulated animals. Subjects with cannula placements that missed bilaterally by 0.3-0.5 mm (n = 8) were included in an anatomical control group. The remaining animals had either unilateral placements (n = 4) or the infusion sites could not be verified (n = 4) because of occluded cannula at the time of the dye injection, and the data from these animals were not included in the subsequent analysis.
Animals receiving both doses of muscimol showed significantly lower levels of submissive behaviors compared with animals in the control group (P < 0.01) ( Fig. 3 ). In addition, animals receiving both the 1.1-and 2.2-nmol dose displayed significantly lower levels of social behavior compared to vehicle controls (P < 0.05). No significant differences were found between the two muscimol groups. Non-social behaviors were not different among all groups, regardless of dose, and no instances of aggression were found. Furthermore, as with Experiment 1, behavioral analysis of the anatomical controls (injection sites localized at least 0.3 mm from the MeA) showed no statistical difference compared to the vehicle control group, indicating that the effects of muscimol on conditioned defeat were site-specific.
Experiment 3: Effect of anisomycin in the BLA or MeA on acquisition of conditioned defeat Figure 4A shows the injection sites for the BLA animals in Experiment 3. Of the 20 BLA animals, 13 had bilateral placements in the BLA. Four subjects had bilateral injections and were used as anatomical controls. In addition, the head cap fell off two subjects, and one additional animal showed high levels of aggression during the training process and was not defeated. These animals were not included in the subsequent analysis and were removed from the study. Figure 4B shows the injection sites for the MeA animals in Experiment 3. Of the 24 MeA animals, 15 showed injection sites localized bilaterally in the MeA. Seven animals had unilateral placements and were thus not included in the analysis. The remaining animals (n = 3) had occluded cannula during ink injection, and therefore cannula placement could not be verified; data from these animals were also removed from the study. Because there were no bilaterally misplaced cannulas in this group, an anatomical control group was not included.
Behavioral data from vehicle-administered animals in both the BLA and MeA groups were combined, as there was no significant difference between the two. In the BLA, the injection of anisomycin before training caused a significant reduction in submissive/defensive behaviors (P < 0.01) 24 h later at testing. These animals also showed an increase in social behavior (P < 0.05) compared to vehicle controls (Fig. 5 ). Non-social and aggressive behaviors were not significantly different compared to controls. In the MeA, anisomycin given before defeat training did not have significant effects on submissive/defensive, aggressive, and social or non-social behavior compared to control animals. Behavioral analysis of the anatomical controls for BLA animals infused with anisomycin showed no significant difference with the vehicle control group.
As indicated in Table 2 , the RA was equally likely to attack the anisomycin and vehicle control groups, as shown by the latency to first attack and total attack duration times, indicating that anisomycin infusions did not alter the normal behavioral profile of the animals. Additionally, there was no difference in the behavior of the RA toward the animals given anisomycin in the BLA versus the MeA.
Discussion
The MeA has long been known to play a key role in the processing of biologically relevant odors, specifically those related to reproductive success. There are few studies examining the potential contribution of the MeA to conditioned fear. The primary aim of Experiments 1 and 2 was to examine this possibility by temporarily inactivating the MeA with the GABA A agonist muscimol and testing the animals in an ethologically relevant model of conditioned fear, in which chemosensory cues are most likely involved. The results demonstrate that infusion of muscimol into the MeA interfered with both the acquisition and expression of conditioned defeat. Specifically, in Experiment 1, animals receiving bilateral infusions of muscimol into the MeA 5 min prior to initial defeat training showed significantly fewer submissive/ defensive behaviors when paired with a non-aggressive intruder 24 h later than did animals receiving infusions of saline. Similarly, in Experiment 2, infusions of muscimol prior to testing with the non-aggressive intruder also resulted in a significant reduction in submissive/defensive behaviors compared to vehicle controls. These data provide support for the view that the amyg- (Blanchard and Blanchard 1972; LeDoux et al. 1990; Jasnow and Huhman 2001; Nader et al. 2001; Davis 2006 ) and demonstrate for the first time that the MeA is a critical component of the neural circuit that controls conditioned defeat.
In Experiment 1, animals receiving both doses of muscimol (1.1 and 2.2 nmol) prior to the acquisition of conditioned defeat displayed significantly lower levels of submissive/defensive behaviors compared to controls, and, importantly, these animals also showed a concomitant increase in pro-social behaviors, including chemosensory investigation of the NAI. This bidirectional effect strongly points to a specific reduction in the acquisition of conditioned defeat rather than a general inhibition of social or locomotor activity. Additionally, analysis of the training (defeat) sessions revealed no significant differences in the aggressive behavior of the resident aggressors toward muscimol-and saline-infused subjects, reducing the likelihood that muscimol infusions somehow altered the stimulus properties of the subjects, thus adversely affecting the normal attack pattern of the RAs. In Experiment 2, muscimol infusions (both 1.1-and 2.2-nmol doses) prior to testing with the NAI (24 h after initial defeat) also caused a significant reduction in submissive/defensive behaviors. However, unlike Experiment 1 where a concomitant increase in prosocial behaviors was observed, making it unlikely that a non-specific or carryover effect had occurred, no such increase was found in Experiment 2. Indeed, muscimol injections significantly decreased social behaviors, and a slight, although non-significant, increase in nonsocial behaviors (including grooming and digging into the corncob bedding) was observed compared to saline controls. However, the overall reduction in conditioned defeat did not appear to be due to a non-specific, sedative-like effect of muscimol on behavior.
The effect of muscimol infusions on the acquisition and expression of conditioned defeat also appears to be anatomically specific to the medial nucleus of the amygdala. Infusions of muscimol that were centered in areas >300-500 µm from the MeA had no significant effect on either the acquisition or expression of conditioned defeat, as these animals showed levels of conditioned defeat similar to controls. Additionally, behavioral data in subjects with unilateral cannulations (either the right or left side) showed an intermediary, although not statistically significant, effect of muscimol on conditioned defeat (data not shown). Finally, animals in the anatomical control group in Experiment 2 did not show an apparent increase in non-social behavior further indicating that muscimol at the doses used in this study does not induce non-specific, ataxic effects on behavior.
Of particular interest are the results from Experiment 1, which demonstrate the involvement of the MeA on the acquisition of conditioned fear using an ethologically relevant model of conditioned fear. Two possible interpretations emerge from these results. The first is that plasticity for biologically relevant odor cues occurs specifically in the MeA, while the BLA mediates the consolidation of fear-related memories. This viewpoint is supported by studies showing a lack of effect of MeA lesions using traditional models of conditioned fear. For example, Nader et al. (2001) showed that while lesions of the CeA and LA (lateral nucleus of the amygdala), or of the entire amygdala, disrupted the acquisition of auditory fear conditioning, lesions of the MeA had no effect. Additionally, Oakes and Coover (1997) showed that lesions of the MeA did not adversely affect a drinking passive-avoidance (dPA) learning task, while lesions of the CeA significantly attenuated dPA. Finally, a more recent study showed that infusions of AP5 into the MeA caused a disruption in the expression, but not acquisition of fear conditioning to an olfactory cue (Walker et al. 2005) . Conversely, however, the study by Luiten et al. (1985) showed that lesions of the MeA in previously defeated rats caused a decrease in active avoidance of male con- Cold Spring Harbor Laboratory Press on November 7, 2016 -Published by learnmem.cshlp.org Downloaded from specifics, suggesting that fear of a previously dominant conspecific is dependent on the MeA. The results from Experiments 1 and 2 confirm and extend these findings in that a significant decrease in submissive/defensive behaviors was observed in muscimol-infused animals exposed to the NAI. One possible interpretation for these contradictory findings is that the present study as well as the Luiten study used an ethological approach, which involves biological odors, to investigate the role of the MeA in fear conditioning. Conversely, other studies suggesting a lack of involvement of the MeA in fear conditioning used more traditional, non-social approaches and non-biological odorants, such as amyl acetate, as the conditioned stimulus (Walker et al. 2005) .
Another possible interpretation is that the MeA may simply communicate necessary chemosensory stimuli associated with socially relevant odors to other areas of the amygdala, such as the BLA, and that the BLA is actually the crucial site required for consolidation of all fear-related plasticity. Thus, the goal of Experiment 3 was to specifically address this possibility by infusing anisomycin, a protein synthesis inhibitor, into either the MeA or BLA during the acquisition phase of conditioned defeat. If plasticity related to socially relevant odor cues occurs in the MeA, then anisomycin infusions in the MeA should disrupt the consolidation process and interfere with conditioned defeat.
The results of Experiment 3 showed that the infusion of anisomycin into the MeA prior to initial defeat training failed to disrupt submissive/defensive behaviors, but that infusions into the BLA significantly reduced these behaviors. These results strongly suggest that the MeA is not a crucial site for the consolidation of fear-related memories that underlie conditioned defeat and are consistent with previous findings on several levels. First, several studies have shown that the site of neural plasticity in-volving olfactory cues occurs in the BLA. Cousens and Otto (1998) showed that pre-and post-training neurotoxic (NMDA) lesions of the BLA blocked both conditioned freezing to a (nonbiologically relevant) olfactory CS as well as to the training context. More recently, Kilpatrick and Cahill (2003) showed that animals that received intra-BLA infusions of tetrodotoxin (TTX) following paired odor-shock presentations caused a disruption in memory consolidation when tested 48 h later in an open-field, place-preference test. The findings in Experiment 3 are also consistent with the Walker (2005) study showing that while infusion of the glutamate receptor antagonists AP5 into the BLA disrupted the acquisition of fear-potentiated startle, AP5 and NBQX failed to reduce FPS when infused into the MeA. These findings suggest that while the BLA is necessary for both the acquisition and expression of FPS, the MeA may only be required for the expression of this behavior. Our findings suggest a similar mechanism. While muscimol disrupted both the acquisition and expression of conditioned defeat, the disruption of protein synthesis via the infusion of anisomycin resulted in a reduction in conditioned defeat only when injected into the BLA, suggesting that plasticity related to odor cues occurs here, rather than in the MeA.
In summary, the findings from the present series of experiments add to the growing body of knowledge regarding the neural mechanisms of conditioned defeat and show for the first time that the MeA may function as a sensory gateway for olfactory stimuli related to biologically relevant odors. We also demonstrated that plasticity for conditioned defeat occurs specifically in the BLA, via its connectivity to the MeA.
Materials and Methods

Animals and housing conditions
Subjects were adult male Syrian hamsters (Mesocricetus auratus; Charles River Laboratories, Wilmington, MA) that weighed 110-135 g and were ∼9 wk old at the time of testing. All subjects were individually housed for 2 wk prior to the start of testing in a temperature ‫ע°02(‬ 2°C) and humidity-controlled room with free access to food and water and kept on a 14:10 h light:dark cycle (lights out at 11:00 h). Resident aggressors (RA) used for defeat training were older (>6 mo), singly housed males weighing between 160 and 180 g. Younger males (2 mo) that weighed between 100 and 110 g and group-housed (five to six per cage) were used as non-aggressive intruders (NAI). The cages of the experimental animals and the resident aggressors were not changed for 1 wk prior to testing. No RA or NAI was used more than twice on the respective test days. All procedures and protocols were approved by the Georgia State University Institutional Animal Care and Use Committee.
Surgical procedures
Subjects were anesthetized with sodium pentobarbital (90 mg/kg, i.p.) and placed into a stereotaxic frame. Two 4.2-mm-long stainless steel guide cannulas (26-gauge) were implanted bilaterally into the brain and aimed at either the medial amygdala (0.5 mm caudal and ‫4.2ע‬ mm lateral relative to bregma) or the basolateral amygdala (0.5 mm rostral and ‫4.3ע‬ mm lateral relative to bregma). In order to prevent damage to the area of interest, the guide cannula was lowered to only 3.9 mm below dura for the MeA and 2.1 mm below dura for the BLA. On the day of injection, a 33-gauge injection needle projected 4.2 mm below the guide cannula, reaching a final depth of 7.6 mm below dura for the MeA and 6.3 mm below dura for the BLA. This injection procedure minimizes damage to the injection site. Following surgery, dummy stylets were placed in the guide cannula to help maintain patency. Hamsters were allowed 7-10 d to recover from surgery prior to the start of behavioral testing, and they were handled each day after surgery by gently restraining them and removing and replacing the dummy stylet in order to maintain patency and habituate the subjects to the injection procedure. 
Social defeat and behavioral testing
The conditioned defeat model has been extensively described elsewhere (Huhman et al. 2003) . Briefly, on the day of social defeat training, animals were transported to the testing room and allowed to acclimate to the environment for 1 h. All training and testing sessions were performed during the first 3 h of the dark phase of the light-dark cycle. Training consisted of one 15-min exposure to the RA in the aggressor's home cage, upon which the RA reliably attacked the experimental hamsters within 60 sec. The following day, animals were again transported to the same testing room, and a NAI was placed into its home cage for 5 min. An animal was considered to show conditioned defeat if the subject exhibited an increase in submissive and defensive behaviors and no aggressive behaviors when the NAI was introduced into its home cage. Conversely, a reduction in conditioned defeat was operationally defined as a significant reduction in the expression of submissive and defensive behaviors. In contrast, non-defeated animals typically exhibit minimal submissive behaviors and show high levels of territorial aggression directed toward the NAI. All training and testing sessions were videotaped via a camera mounted overhead. The videotapes were then transferred to a CD-ROM and later scored by an experimentally blind observer using the behavioral scoring program Hindsight (developed by Scott Weiss). The total duration of four classes of behaviors were scored during the test session: (1) social behavior (stretch, approach, sniff, nose touching, and flank marking); (2) non-social behavior (locomotion, exploration, grooming, nesting, feeding, and sleeping); (3) submissive/defensive behaviors (flight, avoidance, tail up, upright, side defense, full submissive posture, stretch attend, head flag, attempted escape from cage); and (4) aggressive behaviors (upright and side offense, chase and attack, including bite).
Drug infusion
Experiments 1 and 2
The drug infusion procedure was identical for Experiments 1 and 2. Muscimol (Sigma, 1.1 nmol or 2.2 nmol in 200 nL of saline) or vehicle control (200 nL of saline) was infused bilaterally into the MeA or BLA (Experiments 1 and 2) over a 1-min period using a 1-µL syringe and Hamilton mini-pump connected to a 33-gauge needle via polyethylene tubing. The needle was kept in place for an additional 1 min before being removed to ensure complete diffusion of the drug after which the dummy stylet was replaced. Testing began 5 min after drug infusion.
Experiment 3
Anisomycin (Sigma, 0.75 nmol in 200 nL of saline) or vehicle control (200 nL of saline) was infused bilaterally into either the MeA or the BLA using the identical procedures as described in Experiments 1 and 2, except that testing began 30 min after drug infusion. Anisomycin has been shown to impair memory by disrupting protein synthesis and therefore blocking consolidation (Bourtchouladze et al. 1998; Schafe and LeDoux 2000) .
Site verification
At the end of each experiment, hamsters were administered an overdose of sodium pentobarbital and infused with 200 nL of India ink to verify the placement of the needle. They were then perfused transcardially with 10% buffered formalin. The brains were post-fixed in 10% buffered formalin for 3 d before being sectioned on a cryostat. Thirty-micrometer sections were taken and stained with neutral red and coverslipped with DPX. Sections were then examined under a light microscope for placement verification. Only animals with injection sites within 0.3 mm of the BLA or MeA were included in the statistical analysis. Animals with bilateral injections outside of the BLA or MeA were included in a site control group (anatomical controls). Those with unilateral injections (cannula placements within the appropriate site on one side only) were not included in the data analysis.
Experiment 1: Role of the medial amygdala in the acquisition of conditioned defeat
The goal of Experiment 1 was to determine whether the temporary inactivation of the MeA using the GABA A receptor agonist muscimol would significantly reduce the acquisition of conditioned defeat. Animals (n = 42) were matched by weight and randomly assigned to one of three conditions. Hamsters received one of two doses of muscimol (1.1 or 2.2 nmol in 200 nL of saline) or vehicle control (200 nL of saline) 5 min prior to being placed into the home cage of a resident aggressor for 15 min. On the following day, animals were tested drug-free in their own cage against a non-aggressive intruder for 5 min.
Experiment 2: Role of the medial amygdala on the expression of conditioned defeat
The goal of Experiment 2 was to determine whether the temporary inactivation of the MeA using muscimol would significantly reduce the expression of conditioned defeat. Animals (n = 40) were matched by weight and randomly assigned to one of three conditions and placed into the home cage of the resident aggressor for 15 min. On the following day, animals received one of two doses of muscimol (1.1 nmol or 2.2 nmol in 200 nL of saline) or vehicle control (200 nL of saline) 5 min prior to conditioned defeat testing (having a non-aggressive intruder in its cage for 5 min).
Experiment 3: Effects of anisomycin in the medial amygdala and the basolateral amygdala on the acquisition of conditioned defeat
The goal of Experiment 3 was to determine whether plasticity related to conditioned defeat occurs in the MeA or the BLA. Animals (n = 44) were matched by weight and randomly assigned to one of four conditions. The first group (n = 20) consisted of animals with cannulas aimed at the BLA, while the second group (n = 24) was cannulated in the MeA. On the day of training, the animals received either the anisomycin or saline alone and were placed into the home cage of a resident aggressor for 15 min. On the following day, animals were tested in their own cage against a non-aggressive intruder for 5 min. 
